INVESTIGATIONAL NEW DRUG APPLICATIONS
\ɪnvˌɛstɪɡˈe͡ɪʃənə͡l njˈuː dɹˈʌɡ ˌaplɪkˈe͡ɪʃənz], \ɪnvˌɛstɪɡˈeɪʃənəl njˈuː dɹˈʌɡ ˌaplɪkˈeɪʃənz], \ɪ_n_v_ˌɛ_s_t_ɪ_ɡ_ˈeɪ_ʃ_ə_n_əl n_j_ˈuː d_ɹ_ˈʌ_ɡ ˌa_p_l_ɪ_k_ˈeɪ_ʃ_ə_n_z]\
Sort: Oldest first
-
An application that must be submitted to a regulatory agency (the FDA in the United States) before a drug can be studied in humans. This application includes results of previous experiments; how, where, and by whom the new studies will be conducted; the chemical structure of the compound; how it is thought to work in the body; any toxic effects found in animal studies; and how the compound is manufactured. (From the "New Medicines in Development" Series produced by the Pharmaceutical Manufacturers Association and published irregularly.)
By DataStellar Co., Ltd
